CU23358B7 - VACCINE THAT INCLUDES A GARRAPATA CEMENT PROTEIN - Google Patents

VACCINE THAT INCLUDES A GARRAPATA CEMENT PROTEIN

Info

Publication number
CU23358B7
CU23358B7 CU20020238A CU20020238A CU23358B7 CU 23358 B7 CU23358 B7 CU 23358B7 CU 20020238 A CU20020238 A CU 20020238A CU 20020238 A CU20020238 A CU 20020238A CU 23358 B7 CU23358 B7 CU 23358B7
Authority
CU
Cuba
Prior art keywords
vaccine
garrapata
cement protein
ectoparasites
cement proteins
Prior art date
Application number
CU20020238A
Other languages
Spanish (es)
Inventor
Guido Christiaan Paesen
Adama Roseanne Trimnell
Patricia Anne Nuttall
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of CU23358B7 publication Critical patent/CU23358B7/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Insects & Arthropods (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to the use of tick cement proteins in the production of vaccines for protecting animals against the bite of blood-sucking ectoparasites and against the transmission of viruses, bacteria and other pathogens by such ectoparasites. When used as vaccine components, the tick cement proteins of the invention confer broad cross-reactivity against a variety of species of ectoparasite.
CU20020238A 2000-04-25 2002-04-25 VACCINE THAT INCLUDES A GARRAPATA CEMENT PROTEIN CU23358B7 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0010068.5A GB0010068D0 (en) 2000-04-25 2000-04-25 Vaccine composition
GBGB0028606.2A GB0028606D0 (en) 2000-04-25 2000-11-23 Vaccine composition

Publications (1)

Publication Number Publication Date
CU23358B7 true CU23358B7 (en) 2009-03-16

Family

ID=9890483

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20020238A CU23358B7 (en) 2000-04-25 2002-04-25 VACCINE THAT INCLUDES A GARRAPATA CEMENT PROTEIN

Country Status (5)

Country Link
JP (1) JP4925236B2 (en)
CN (1) CN101406696A (en)
AT (1) ATE551068T1 (en)
CU (1) CU23358B7 (en)
GB (2) GB0010068D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540583B (en) * 2018-05-29 2022-07-15 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) Sickle rhipicephalus vacuole sortilin molecule and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723945D0 (en) * 1997-11-12 1998-01-07 Nat Environmental Research Cou Tissue cement

Also Published As

Publication number Publication date
CN101406696A (en) 2009-04-15
GB0010068D0 (en) 2000-06-14
ATE551068T1 (en) 2012-04-15
JP2003531177A (en) 2003-10-21
JP4925236B2 (en) 2012-04-25
GB0028606D0 (en) 2001-01-10

Similar Documents

Publication Publication Date Title
ATE451119T1 (en) SUBUNITY VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS
WO2004030608A3 (en) Nanoemulsion vaccines
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINATES TO IMPROVE THE CROSS IMMUNE PROTECTION FUNCTION
ATE396739T1 (en) DEVELOPMENT OF A VACCINE FOR THE PREVENTION OF FILOVIRUS INFECTIONS IN PRIMATES
DK1326633T3 (en) Composition comprising immunogenic microparticles
NO20034244L (en) Microbial feed for aquaculture and agriculture
DE602004028029D1 (en) Rwendung
BR0110278A (en) A vaccine, antibody or antiserum composition, methods of producing an antibody or antiserum and immunizing an animal against a blood-eating ectoparasite, tick cement protein, and use of a protein tick cement
ATE413888T1 (en) SALMONELLA VACCINE
MXPA03006971A (en) Hepatitis b virus treatment.
DE60124526D1 (en) METHOD FOR IDENTIFYING HELICOBACTER ANTIGENES
WO2004043404A3 (en) Process for designing inhibitors of influenza virus non-structural protein 1
DE69836759D1 (en) TISSUE CEMENT PROTEINS FROM RHIPICEPHALUS APPENDICULATUS
EA200301151A1 (en) VACCINE AGAINST NATURAL DASH
CU23358B7 (en) VACCINE THAT INCLUDES A GARRAPATA CEMENT PROTEIN
NO20062469L (en) Streptococcus phocae vaccine
ATE487489T1 (en) RECOMBINANT INTRACELLULAR PATHOGEN IMMUNOGENIC COMPOSITIONS AND METHODS OF USE
ATE476987T1 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDASIS
DE60238554D1 (en) Vaccine against Infectious Diseases
WO2004082596A3 (en) Yersinia species compositions
ATE353226T1 (en) ADJUVANT COMPOSITION CONTAINING FHA OR AN FHA FRAGMENT IN FREE FORM
ATE495757T1 (en) LIVE ATTENUATE BACTERIAL VACCINE
CY1107374T1 (en) FISH VACCINE AGAINST PISCIRICKETTSIA SALMONIS
ATE424844T1 (en) COMBINATION VACCINE FOR POULTRY
WO2006037383A8 (en) Piscirickettsia salmonis antigens and use thereof